Pharm Asia Drug plan focuses on expanding the manufacturing facilities and capacity for non-sterile pharmaceutical products as per WHO-cGMP norms.

This will done by increasing capabilities and manufacturing capacities.. The expansion of the plant will add a new manufacturing suit including modern manufacturing and utility facility of oral/external liquid and ointment preparations and this provide controlled/safe environment for handling materials and this will done by increasing the capabilities of manufacturing process.

    Our expansion towards the formulation are :

  • Ointment preparation
  • Liquid external preparation
  • Liquid oral preparation
  • Tablet preparation